Homocarnosine having the chemical formula ##STR1## or physiologically acceptable salts thereof are specifically effective as a medicine for treatment of inflammatory diseases.

Acylated sec-alkylanilines and acylated alkoxy-sec.alkylanilines of the formula I are valuable microbicides. They can be used in the form of compositions especially for controlling phytopathogenic fungi, such as Phytophthora, Plasmopara, Pythium, Puccinia, Cercospora, Erysiphe and others. The compounds have a systemic action.

A process for preparing a parenteral solution for treating skin diseases comprising the steps of: (1) freeze-drying an aqueous extract of paramecium to obtain a dry powder P.sub.1, (2) dissolving the dry powder P.sub.1 in water and separating the aqueous solution into a high-molecular-weight portion A and a low-molecular-weight portion B, (3) freeze-drying an aqueous solution of the portion B to obtain a dry powder P.sub.2, and (4) dissolving the dry powder P.sub.2 in an excipient to formulate t...

An improved vaccine and method for immunizing cattle to Shipping Fever Complex type Bovine Respiratory Disease (BRD) which employs an intradermally administered vaccine containing a live culture of Pasteurella sp., particularly, Pasteurella hemolytica. Innoculation is carried out before the animals are subjected to stress factors, including weaning and transportation to feedlots. Also described is a method for preparing the vaccine by incubation of P. hemolytica within an infusion broth.

A method and a kit for testing a plant for a suspected antigen. A sample of the plant is taken and rubbed between first and second pads to extract sap from the sample and to collect the sap on the first pad. The sap is transferred to a liquid solution, and that solution is tested for the suspected antigen. This may be done by contacting the solution with a tag antibody and with a carrier having a capture antibody so that a tag antibody-antigen-capture antibody complex forms on the carrier if the...

A method of treating a neurodegenerative disease which comprises administering 5-bromo-4-(4-morpholinyl)-2-pyrimidinamine or 4-(4-morpholinyl)-2-(1-piperazinyl)thieno[3,2-d]pyrimidine or a pharmaceutically acceptable salt thereof.

Insulin-like growth factor I (IGF I) and pharmaceutical compositions comprising IGF I are useful in improving glomerular filtration and renal plasma flow and can be used for the treatment of patients suffering from renal diseases and for the preparation of therapeutic combinations for treatment of renal diseases.

A therapeutic composition which contains a potentiating or safening amount of an aqueous surfactant in combination with a bactericidal agent and/or a biological response modifier is described herein. The disclosure further describes an improved method for treating mastitis by administering the composition to an afflicted mammal. Additionally, the disclosure describes a method for screening suitable formulations for treating infectious diseases.

A process for the propagation of bacteria in a tissue culture system and the preparation of a bacterin therefrom which bacterin has the capability of protecting fowl not only against homologous serotypes of the same organism, but also against heterologous serotypes of the same organism.

The present invention discloses a vaccine for the prevention of rotavirus caused diseases in humans. The vaccine is prepared from attenuated, immunogenic rhesus rotavirus which has been characterized to be antigenically similar, if not identical, to human rotavirus serotype 3.